- page

Scroll to explore

Scroll back top

8 September 2020

Join our free webinar : Shedding new light on GPCR drug discovery with a novel biosensor technology ...

1 September 2020

Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling ...

Domain Therapeutics presents posters at the American Association for Cancer Research Virtual Annual ...

Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at...

Domain presents a novel approach to study RTK mutations and the effects of inhibitors at the AACR 20...

Domain presents target identification strategy to identify novel immune checkpoint from GPCR-ome at ...

Domain presents the best-in-class potential of its EP4 antagonist drug candidate at the AACR 2020

Domain Therapeutics contributes to the launch of Find Therapeutics

DOMAIN at the BIO Digital conference 2020

Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, fo...